CONCLUSION: There is variation in CD rate relative to attending shift change, but the overall variation is small in magnitude. There are few clinically meaningful differences in obstetric interventions and outcomes based on proximity to shift change.
OBJECTIVE:
To determine how inpatient opioid utilization after cesarean section is affected by as-needed postpartum analgesia compared to scheduled dosing of a multimodal analgesic regimen. STUDY DESIGN: Retrospective cohort study of singleton cesarean deliveries at 37 weeks of gestation at a tertiary university hospital from [2013] [2014] [2015] [2016] . In month 21 of 48-month study period, a new institutional protocol for postpartum pain management was implemented which consisted of scheduled dosing of a multimodal analgesic regimen (Figure 1 ). Prior to this, patients received pain relief only as needed, by reporting elevated pain scores to nursing staff. Patients were excluded for the following: NSAID or opioid allergies, protocol deviations, transition month deliveries, history of drug abuse, positive urine toxicology, general anesthesia, prolonged hospitalization, postpartum hemorrhage, hypertensive disorders of pregnancy, incomplete records. Outcomes evaluated were the percentage of patients receiving oxycodone and mean oxycodone consumption per inpatient day (grams). Segmented regression analysis of interrupted time series was performed to estimate linear time trends of oxycodone consumption pre-and post-protocol implementation. RESULTS: A total of 6,508 deliveries were included: 2,807 women received as-needed postpartum analgesia and 3,701 women received scheduled postpartum analgesia. Opioids were administered to 80.2% and 75.4% of patients under the as-needed and scheduled protocols, respectively (p<0.0001). After adjusting for potential confounders, a significant downward trend in the percentage of patients receiving oxycodone(0.004% per month; p<0.006) was noted before implementation of the scheduled pain management protocol ( Figure 2A ). There was no shift at the time of implementation, and no change in the slope of the trend after implementation. Among patients who received oxycodone, monthly means of oxycodone consumption per day ranged from 20.3-29.6 grams before implementation and from 20.1-25.6 grams after implementation ( Figure 2B) ; no trend existed before or after implementation of the new protocol, and there was no shift at the time of implementation. CONCLUSION: In uncomplicated cesarean deliveries at term, scheduled multimodal analgesia does not increase the percentage of women who receive oxycodone or mean oxycodone consumption per inpatient day compared to as-needed analgesia. OBJECTIVE: Postpartum hemorrhage (PPH) remains a leading cause of severe maternal morbidity and mortality. Both regional and national safety initiatives have sought to reduce harm from this condition, yet how to best identify clinically significant PPH episodes is unclear. The objective of this study was to characterize PPH in a major hospital system. STUDY DESIGN: Patients delivering between July 2014 and July 2017 in a four-hospital medical system performing 14,000 deliveries per year were analyzed. Data was obtained by querying the electronic medical record (EMR). Measures of postpartum hemorrhage were classified as: level 1 (any uterotonic), level 2 (ICD 9 or 10 PPH diagnosis code), level 3 (Bakri balloon and/or transfusion 1-3 units RBCs), or level 4 (hysterectomy and/or 4 units RBCs). Hematocrit drop from the last pre-delivery measurement to lowest postpartum level was analyzed in relation to these PPH classifications. For this analysis we presumed hematocrit drop 40% represented major PPH. RESULTS: 43,657 deliveries were included in the analysis including 1621 with level 1, 1326 with level 2, 778 with level 3, and 248 with level 4 PPH. As demonstrated in Figure 1 , PPH categories 3 and 4 were associated with higher proportions of major PPH with 40% hematocrit drops. 30% and 31% of women with PPH level 3 and 4 had hematocrit drops of 40%. 116 women without a diagnosis of PPH (0.4%) had a decrease of this magnitude. The median hematocrit drops for PPH level 1 through 4 were 15.5%, 20.6%, 33.4%, and 33.4%, respectively, versus a 12.6% drop for patients hospitalized for delivery with no PPH (p<0.01). When transfusion was analyzed in relation to hematocrit drop, hematocrit drops were larger for women undergoing transfusion but similar for women receiving 1-3 versus 4 units RBCs (Figure 2 
